… in pro-thrombotic phenotype observed in COVID-19 patients [… responsible for COVID-19
associated coagulopathy [14,15]. In … and the coagulation system, thrombotic complication, and …

… available on an important aspect of COVID‐19, that is, its … COVID‐19 who are at risk of a
coagulopathy and thrombotic … be affected due to the current COVID‐19–related measures. A …

… Whether early thromboelastometry analysis at hospital admission can predict outcome (thrombosis
and mortality) in COVID-19 will be analyzed at a later stage of this research project. …

… Severe COVID-19 leads to a cytokine storm and coagulopathy is a known consequence
of … sepsis-induced coagulopathy (SIC) and disseminated intravascular coagulation (DIC) [82]. …

… In this review, we summarized the main findings regarding the cellular mechanism of
COVID-19-associated coagulopathy that may provide evidence for the use of conventional therapy …

… The presence of coagulopathy as part of the systemic … feature of severe coronavirus
disease 2019 (COVID-19). … with COVID-19, which characterize the risk of thrombotic events. …

… at high risk of COVID-19-associated coagulopathy [14]… coagulopathy in COVID-19 Having
identified the various populations vulnerable to coagulopathy-associated severity of COVID-19…

… However, the role of blood cells is not well understood in COVID-19 patients. In addition, …
of thrombosis in severe COVID-19 patients. We outline the major events of coagulopathies, …

… Severe cases with COVID-19 is associated with a … thrombosis and acute pulmonary
embolism. Pulmonary intravascular coagulopathy is the characteristic coagulopathy in COVID-19. …

… vein thrombosis has also reported in COVID-19 patients in … caused by coagulopathy that
appears in COVID-19 patients [33]… The evaluation of the sepsis-induced coagulopathy is a great …